Menten AI

Generative AI Platform for Peptide Therapeutics

[Menten AI @menten_ai]

We're excited to share that our CEO, Hans Melo, will be presenting at NextGen Biomed on March 25th, where he’ll discuss Menten AI's platform, MAUD 1.0. 🚀
If you’re attending in London, UK - let’s meet! 👋
#peptides #nextgenbiomed #drugdiscovery #ai

[Menten AI @menten_ai]

Biocom this February 📍
Andrea McNeal, Our VP of Business Development, will be attending to connect with partners and discuss how we’re advancing AI-driven peptide drug discovery. Reach out to set up a meeting! 👋

#peptides #ai #drugdiscovery #partnering

[Menten AI @menten_ai]

🚀 Menten AI's Platform launch
Today, we’re excited to introduce MAUD 1.0 — our next-generation system for AI-driven design of cyclic peptide medicines.
🎥 Watch a short overview of what we do:
https://t.co/jbBPzM1qEu

#DrugDiscovery #Peptides #GenerativeAI #MAUD #Innovation #AI

[Menten AI @menten_ai]

We’re excited to be in San Francisco as we continue advancing peptide therapeutics. 🚀
If you’re in town make sure to catch up with Andrea McNeal, our VP Business Development! 👋

#jpmorgan #jpm #peptides #ai #drugdiscovery

[Menten AI @menten_ai]

Wishing our partners, collaborators, and the broader scientific community a joyful holiday season! ✨
Thank you for being part of our journey in shaping the future of peptide therapeutics — we’re excited for what’s ahead in 2026. 🚀
#peptidetherapeutics #drugdiscovery #ai

[Menten AI @menten_ai]

Menten AI is excited to share that our co-founder and Rosetta developer, Dr. Vikram Mulligan, published the first paper from his Masala project—an open-source suite designed to succeed Rosetta👏https://t.co/eSUXQeVL5w
A big step forward for protein and synthetic peptide design🚀

[Menten AI @menten_ai]

Excited to announce our collaboration with Bristol Myers Squibb @bmsnews applying Menten AI’s generative AI platform for peptide optimization. 🤝
#genai #drugdiscovery #partnerships

https://t.co/Wd4urwIkeh

[Menten AI @menten_ai]

Drug discovery starts with having the right target ✅
Menten AI’s target assessment tool can uniquely model protein dynamics and identify novel hot-spot regions amenable for cyclic peptide design 🎯
#generativeai #artificialintelligence #drugdiscovery #peptides #biotechnology

[Menten AI @menten_ai]

The constrained peptide therapeutics market is expected to grow to $17.38 billion by 2040 at a CAGR of 38.94%! 🚀vs. ~9% CAGR for small molecules and biologics. Peptide therapeutics will become a major player.🏆
https://t.co/F1NjtnDWRS
#peptides #drugdiscovery #generativeAI #ML

[Menten AI @menten_ai]

APS is happening now!
Don’t miss the chance to meet Stephan Kudlacek and learn about how Menten AI utilizes Generative AI to advance #peptide drug discovery! 👋

#peptides #aritificialintelligence #machinelearning #drugdiscovery

[Menten AI @menten_ai]

Read about how in silico design can accelerate the development of peptides - a therapeutic modality that overcomes many limitations of small molecule and biologic drugs 🎯: https://t.co/ThCb5TB0lN

https://t.co/OscnUkqtDw

[Menten AI @menten_ai]

Can you believe Menten AI achieved in vivo efficacy in only 4 weeks straight out of in silico design? 🧐

To find out how, don’t miss Dr. Stephan Kudlacek’s discussion at APS on June 26th! https://t.co/XWDEkQS3l1

Not at APS? Don’t hesitate to reach out! https://t.co/uHNehRB82o

[Menten AI @menten_ai]

Ever wondered how multiple molecules fit together? 🤔

Check out @menten_ai's work on predicting multibody molecular docking using a quantum annealer.

#drugdiscovery #drugdesign #quantumcomputing #peptides #biotechnology

https://t.co/oOfPnENbfK

[Menten AI @menten_ai]

Come meet us at the American Peptide Symposium on June 28👋
Our Associate Director, Stephan Kudlacek, will be discussing Menten AI's most advanced generative AI platform for the design and optimization of cyclic peptides
Visit our website https://t.co/OscnUkqtDw
See you there!🎉

[Menten AI @menten_ai]

“While quantum computing hardware capable of running these algorithms is still being developed, classical computing tools like NVIDIA cuQuantum are crucial for advancing quantum algorithm development” - Alexey Galda, Quantum Principal Scientist
#biotech
https://t.co/Vf0MM8G1Ds

[Menten AI @menten_ai]

Bio-QML Challenge in the QHack Open Hackathon, meet you there 💻🧬💊 #biotech #QuantumComputing

[PennyLane @PennyLaneAI]

#QHack2022 Prize Announcement 📣

Enter the Bio-QML Challenge in the QHack Open Hackathon for your chance to win:

12-week paid remote internship at @menten_ai 🌟

Swag pack 🌟

More prize announcements to come

Sign up today at https://t.co/EdmmMI4ne2

[Menten AI @menten_ai]

Our drug discovery efforts just got boosted by @XanaduAI ’s @pennylaneai We are excited to integrate this new technique into our drug design pipeline.

https://t.co/nUrUw92ypE

[Menten AI @menten_ai]

So excited to be part of #QHack2022 🧪💻
#QuantumComputing #Biotechnology

[PennyLane @PennyLaneAI]

Check out the #QHack2022 sponsors! 🤩 (1/2)

@agnostiqlabs
@AQT_GmbH
@Atom_Computing
@awscloud
@CERNquantum
@creativedlab
@EntropicaLabs
@GoogleQuantumAI
@qiskit
@meetIQM
@menten_ai
@MultiverseQC

Sign-ups open tomorrow (Jan 5th) at 12 PM (noon) EST

https://t.co/EdmmMI4ne2

[Menten AI @menten_ai]

@mark_fingerhuth @QuantumDaily @XanaduAI @dwavesys @1QB_IT @ISARACorp @proteinqure @Qindom_Inc That is correct and we have already contacted Crunchbase to correct this mistake as soon as possible.

[Social Impact Capital @socialimpactcap]

Congrats to our portfolio company @menten_ai for being the first company ever to design a peptide using quantum computing!